To our knowledge, it is the first report showing that efficient knockdown of PI3K or MAPK gene by shRNA could sufficiently block MCL-1 expression in MM cells and resulted in consequent cell death, which offers a potential to utilize shRN/RNA interference as an alternative of chemotherapy for treat drug-resistant MM treatment. Here, MCL1 is linked to Miyoshi myopathy.